Progel Vascular Sealant

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 158 participants.

Also called NCT01959503

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 158 participants (enrolled count) (from the registry)
Sponsor
  • C. R. Bard Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01959503
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01959503. Randomized; single masking; primary purpose treatment. Start 2013-11 (registry gives no type); primary completion 2014-12 (actual). Results posted on 2017-01-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Progel Vascular Sealant
Condition
Aortic Valve Stenosis
Condition
Aneurysm of Ascending Aorta
Condition
Aortic Valve Disorder
Condition
Bicuspid Valve Disorder
Intervention (Device)
Progel Vascular Sealant
Intervention (Device)
Gelfoam Plus
Lead sponsor
C. R. Bard (class: industry)

Record details

Record id
cardio:ct-nct01959503
Content hash
f9f53aaf1fec1f94a3746287a1dc10e9ab640b2b57a9125a176be797b99457e3